PATH vs QDEL · P/E 19, rev $1.61B vs rev $2.78B
Uipath Inc (PATH) versus Quidel Corporation (QDEL) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Quidel Corporation (QDEL) is a medical devices company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported QDEL revenue for 2024-12-29 was $2.78B. Net income was -$2.05B. Revenue was down 7.2% from 2023-12-31 to 2024-12-29. QDEL currently screens at market cap $895.3M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. QDEL currently screens at market cap $895.3M.
Not investment advice. Open the PATH and QDEL stock pages for the full models.
Not investment advice.